BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2020-02403 Chronic Pancreatitis Registry Zurich: A Cohort Study non clinical, involving persons monocentric A Prof. Dr. med. Felix Beuschlein University Hospial Zurich University Hospial Zurich, Department of Endocrinology, Diabetes and Clinical Nutrition, Zurich
Kantonale Ethikkommission Zürich 17.11.2020
2020-02402 Identification of molecular mechanisms and predictive factors for the beneficial effect of darvadstrocel (Alofisel®) for the treatment of Crohn’s disease associated fistulae. personal data/biological material monocentric Prof. Dr. Michael Scharl Universitätsspital Zürich Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich, Zürich
Kantonale Ethikkommission Zürich 13.10.2020
2020-02401 Swiss Renal Registry and Quality Assessment Program personal data/biological material monocentric Prof. Patrice M. Ambühl Swiss Society of Nephrology Institute of Nephrology, Stadtspital Waid, Zürich
Kantonale Ethikkommission Zürich 27.10.2020
2020-02399 Determination of iron status in women in Switzerland and of the factors influencing iron absorption personal data/biological material monocentric Dr. Isabelle Herter-Aeberli ETH Zurich ETH Zurich, Zurich
Kantonale Ethikkommission Zürich 10.11.2020
2020-02398 A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell
Lung Cancer with Disease Progression On or After Platin More ...
clinical trial drugs phase 3 multicentric C Professor Solange Peters Mirati Therapeutics, Inc. Centre Hospitalier Universitaire Vaudoi Lausanne, Lausanne
University Hospital of Geneva, Geneva
KSW Kantonsspital Winterthur, Winterthur
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Zürich, Commission Cantonale d'éthique de la recherche Genève (CCER) 16.03.2021 Study has ended
2020-02397 Impact de la COVID-19 en EMS : Santé et stratégies d’adaptation des personnes âgées et de leurs proches non clinical, involving persons multicentric A Pr Claudia Ortoleva Bucher Institut et Haute Ecole de Institut et Haute Ecole de la Santé La Source, Lausanne
Berner Fachhochschule BFH, Bern
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Bern 15.12.2020 Study has ended
2020-02396 Characterization of prevalence, type, treatment, burden of disease and predictors of respiratory symptoms in very prematurely born children in the Zurich area non clinical, involving persons monocentric A Prof. Dr. med. Susi Kriemler Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich Institut für Epidemiologie, Biostatistik und Prävention, Zürich
Kantonale Ethikkommission Zürich 22.12.2020 yes
2020-02394 EFC16295 - A Phase 3 open-label, multicenter study of the safety, efficacy and pharmacokinetics of intravenous recombinant coagulation Factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIF More ... clinical trial drugs phase 3 monocentric C Prof. Dr. med. Manuela Albisetti Pedroni Bioverativ Therapeutics Inc. (a Sanofi Company) Universitäts-Kinderspital Zürich – Eleonorenstiftung, Zürich
Kantonale Ethikkommission Zürich 24.11.2020 yes Study has ended
2020-02393 GR41987 A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA clinical trial drugs phase 3 monocentric C Dr. Katja Hatz Roche Pharma (Schweiz) AG Vista Klinik, Binningen
Ethikkommission Nordwest- und Zentralschweiz EKNZ 26.11.2020 Study has ended
2020-02392 Motor and non-motor outcomes of deep brain stimulation personal data/biological material monocentric Prof Paul Krack Inselspital Bern Inselspital, Bern
Kantonale Ethikkommission Bern 27.07.2021 Study has ended
2020-02391 A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. Chiara Zecca Merck Healthcare KGaA Ospedale Regionale di Lugano, Lugano
Inselspital, Universitätspital Bern, Bern
Kantonsspital Aarau, Aarau
Comitato etico cantonale Ticino Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern 19.01.2021 Study has ended
2020-02390 Cardiac function in patients with Duchenne Muscular Dystrophy treated with Tamoxifen compared to Placebo personal data/biological material monocentric Prof. Dr. med. Dirk Fischer Universitätskinderspital beider Basel (UKBB), Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 19.10.2020
2020-02389 Postoperative complications at the Luzerner Kantonsspital personal data/biological material monocentric PD Dr. med. Christian Fankhauser Luzerner Kantonsspital, Klinik für Urologie Luzerner Kantosspital, Luzern
Ethikkommission Nordwest- und Zentralschweiz EKNZ 26.11.2020
2020-02388 Feasibility of technology-based cognitive-motor training in rehabilitation: A pilot-trial clinical trial other clinical trials multicentric A Prof. Eling D. de Bruin ETH Zurich ETH Zurich, Zurich
Rehaklinik Zihlschlacht, Zihlschlacht
Rehaklinik Dussnang, Dussnang
Rehaklinik Seewis, Seewis
Kantonale Ethikkommission Zürich Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich 01.12.2020
2020-02387 Impact of gut microbiota and immune contexture on effectiveness of neo-adjuvant chemo-radiotherapy in locally advanced rectal cancer personal data/biological material multicentric Prof. Dr. med. D. Christoforidis EOC EOC Surgical Department, Lugano
Unità di ricerca clinica/Servizio di Radioterapia Clinica Luganese Moncucco, Lugano
Comitato etico cantonale Ticino Comitato etico cantonale Ticino 09.11.2020
2020-02386 The Lugano classification for diverticulitis non clinical, involving persons monocentric A Prof. Dr.med EOC Surgery Department EOC Surgery Department, Lugano
Comitato etico cantonale Ticino 29.10.2020 Study has ended
2020-02385 A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Participants With Recurrent or Metastatic Squamous Cell Carcinoma of the Head a More ... clinical trial drugs phase 3 multicentric C Dr. Petr Szturz AstraZeneca AB CHUV, Centre hospitalier universitaire vaudois, Lausanne
Inselspital Bern, Universitätsklinik für Medizinische Onkologie, Bern
Universitätsspital Basel - Klinik für Onkologie, Basel
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern 09.03.2021 Study has ended
2020-02384 Transcantonal early detection and intervention in adolescents and young adults with high psychosis risk (PsyYoung) non clinical, involving persons multicentric A Christian Huber CHUV UPK Basel, Basel
Unité de psychiatrie du jeune adulte / HUG, Geneva
Service de Psychiatrie générale-DP/CHUV, Lausanne
Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD), Commission Cantonale d'éthique de la recherche Genève (CCER) 08.02.2021 yes Study has ended
2020-02383 Characterization of intestinal microbiota in children with inborn errors of metabolism (IEM) non clinical, involving persons monocentric A Prof. Dr. med. Johannes Häberle ETH Zürich Universitäts-Kinderspital, Zürich
Kantonale Ethikkommission Zürich 17.11.2020 yes Study has ended
2020-02381 Suivi clinique rétrospectif et prospectif des patients ayant bénéficié d’une fermeture percutanée de l’appendice auriculaire gauche non clinical, involving persons monocentric A Dr Stéphane Noble Service de Cardiologie Hôpitaux universitaires de Genève, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 09.02.2021